Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Anderson

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|December 1, 1984
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonistsJ H Jones, P S Anderson, J J Baldwin, et al.
Journal of Medicinal Chemistry|December 1, 1989
Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activityS L Graham, K L Shepard, P S Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinomaH O Smith, P S Anderson, D Y Kuo, et al.
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
Journal of Medicinal Chemistry|March 1, 1991
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitorsT A Lyle, C M Wiscount, J P Guare, et al.
Journal of Medicinal Chemistry|February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonistsW J Thompson, P S Anderson, S F Britcher, et al.
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptaseS D Young, S F Britcher, L O Tran, et al.
Endocrinology|July 1, 1989
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensisD J Pettibone, B V Clineschmidt, P S Anderson, et al.
Journal of Medicinal Chemistry|August 18, 1995
Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonistM E Duggan, A M Naylor-Olsen, J J Perkins, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|December 1, 1984
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonistsJ H Jones, P S Anderson, J J Baldwin, et al.
Journal of Medicinal Chemistry|December 1, 1989
Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activityS L Graham, K L Shepard, P S Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinomaH O Smith, P S Anderson, D Y Kuo, et al.
Drug Design and Discovery|January 1, 1993
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.
Journal of Medicinal Chemistry|March 1, 1991
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitorsT A Lyle, C M Wiscount, J P Guare, et al.
Journal of Medicinal Chemistry|February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonistsW J Thompson, P S Anderson, S F Britcher, et al.
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptaseS D Young, S F Britcher, L O Tran, et al.
Endocrinology|July 1, 1989
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensisD J Pettibone, B V Clineschmidt, P S Anderson, et al.
Journal of Medicinal Chemistry|August 18, 1995
Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonistM E Duggan, A M Naylor-Olsen, J J Perkins, et al.
Pageof 9